LeMaitre Vascular designs and sells medical devices used in open and endovascular surgery of the peripheral vasculature. Its portfolio includes grafts, catheters, patches, valvulotomes and related instruments for treating peripheral arterial disease, dialysis access and other vascular conditions. Surgeons and hospitals are the primary customers; the company focuses on a specialized niche rather than broad cardiovascular implant markets.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 64.2 | — | 13.8 | 18.1% |
| Q3 2025 | 61 | — | 17.4 | 57.7% |
| Q4 2025 | 64.5 | — | 15.6 | 41.4% |
| Q1 2026 | 66.5 | — | 15.7 | 44.8% |
| Q2 2026 | 70.4 | 9.6% | 17.1 | 23.7% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Amplitude, Inc. (AMPL), Diversified Healthcare Trust (DHC), Allegiant Travel Company (ALGT), Astrana Health, Inc. (ASTH), Innodata Inc. (INOD), Republic Bancorp, Inc. (RBCAA)